ABC News & Headlines – Australian Broadcasting Corporation·3 min read·medium
Multiple sclerosis patients given PBS lifeline amid drug pricing dispute
C
Clare Armstrong✦AI Summary
Australian Health Minister Mark Butler has secured a temporary agreement to keep three MS medications on the PBS while a review is conducted. This move avoids a scenario where patients would have been forced to pay up to $33,000 annually for their treatment.
MS drugs including Ocrevus, Kesimpta and Lemtrada were part of the pricing stoush. ( Unsplash: Etactics )
healthbusiness
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in